Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Boostrix

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
BACKGROUND We estimated the vaccine effectiveness (VE) of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2012
Review
2012
SummaryAbstractBoostrix® is a three-pertussis component, combined, reduced-antigen content tetanus, diphtheria, and acellular… Expand
  • table I
  • table II
  • table III
  • table IV
  • figure 1
Is this relevant?
2011
2011
BACKGROUND Older adults, especially those over 65 years, are at risk of more severe morbidity from diphtheria, tetanus and… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 4
Is this relevant?
2011
2011
  • MMWR. Morbidity and mortality weekly report
  • 2011
  • Corpus ID: 21322585
On July 8, 2011, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus toxoid, reduced… Expand
Is this relevant?
2011
2011
  • Y. Ma, M. Qin, +7 authors M. Sun
  • Zhonghua shi yan he lin chuang bing du xue za zhi…
  • 2011
  • Corpus ID: 1602266
OBJECTIVE In order to search the preparation process and optimazing dosage ratio of adsorbed diphtheria-tetanus-acellular… Expand
Is this relevant?
2010
2010
Pertussis continues to circulate in Chinese communities and older children, adolescents and adults are sources of infection for… Expand
Is this relevant?
Review
2009
Review
2009
Pertussis remains a serious problem in many countries. Even in countries with high vaccine coverage and a long vaccination… Expand
Is this relevant?
2009
2009
  • MMWR. Morbidity and mortality weekly report
  • 2009
  • Corpus ID: 30102812
On December 4, 2008, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus toxoid, reduced… Expand
Is this relevant?
2005
2005
  • Taff Jones
  • IDrugs : the investigational drugs journal
  • 2005
  • Corpus ID: 25236141
GlaxoSmithKline plc has developed and launched Boostrix, a subunit vaccine for use in adolescents and adults as a booster… Expand
Is this relevant?